Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22


Patients expectations and fulfilment of expectations before and after treatment for suspected coronary artery disease assessed with a newly developed questionnaire in combination with established health-related quality of life questionnaires.

Odell A, Bång A, Andréll P, Widell C, Fryklund H, Kallryd A, Tygesen H, Grip L.

Open Heart. 2017 Mar 6;4(1):e000529. doi: 10.1136/openhrt-2016-000529. eCollection 2017.


Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).

Redfors B, Angerås O, Råmunddal T, Petursson P, Haraldsson I, Dworeck C, Odenstedt J, Ioaness D, Ravn-Fischer A, Wellin P, Sjöland H, Tokgozoglu L, Tygesen H, Frick E, Roupe R, Albertsson P, Omerovic E.

J Am Heart Assoc. 2015 Jul 14;4(7). pii: e001995. doi: 10.1161/JAHA.115.001995.


Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.


Clinical decision support system (CDSS)--effects on care quality.

dos Santos MA, Tygesen H, Eriksson H, Herlitz J.

Int J Health Care Qual Assur. 2014;27(8):707-18.


Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A.

N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26.


Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.


Sleep, arousal and health-related quality of life in men and women with coronary artery disease.

Johansson A, Svanborg E, Swahn E, Ejdebäck J, Tygesen H, Edell-Gustafsson U.

J Clin Nurs. 2011 Oct;20(19-20):2787-801. doi: 10.1111/j.1365-2702.2011.03787.x. Epub 2011 Jul 22.


Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M.

N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.


Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2.


Heart rate variability in premenstrual dysphoric disorder.

Landén M, Wennerblom B, Tygesen H, Modigh K, Sörvik K, Ysander C, Ekman A, Nissbrandt H, Olsson M, Eriksson E.

Psychoneuroendocrinology. 2004 Jul;29(6):733-40.


Intensive home-based exercise training in cardiac rehabilitation increases exercise capacity and heart rate variability.

Tygesen H, Wettervik C, Wennerblom B.

Int J Cardiol. 2001 Jul;79(2-3):175-82.


Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients.

Wennerblom B, Lurje L, Karlsson T, Tygesen H, Vahisalo R, Hjalmarson A.

Int J Cardiol. 2001 Jun;79(1):61-9.


Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure.

Tygesen H, Rundqvist B, Waagstein F, Wennerblom B.

Am J Cardiol. 2001 Jun 1;87(11):1308-11. No abstract available.


Reduced heart rate variability in ischemic heart disease is only partially caused by ischemia. An HRV study before and after PTCA.

Wennerblom B, Lurje L, Solem J, Tygesen H, Udén M, Vahisalo R, Hjalmarson A.

Cardiology. 2000;94(3):146-51.


Patients with uncomplicated coronary artery disease have reduced heart rate variability mainly affecting vagal tone.

Wennerblom B, Lurje L, Tygesen H, Vahisalo R, Hjalmarson A.

Heart. 2000 Mar;83(3):290-4.


Long-term effect of endoscopic transthoracic sympathicotomy on heart rate variability and QT dispersion in severe angina pectoris.

Tygesen H, Wettervik C, Claes G, Drott C, Emanuelsson H, Solem J, Lomsky M, Rådberg G, Wennerblom B.

Int J Cardiol. 1999 Aug 31;70(3):283-92.


Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes.

Tygesen H, Andersson B, Di Lenarda A, Rundqvist B, Sinagra G, Hjalmarson A, Waagstein F, Wennerblom B.

Int J Cardiol. 1999 Feb 28;68(2):171-7.


Heart rate variability after acute myocardial infarction in patients treated with atenolol and metoprolol.

Lurje L, Wennerblom B, Tygesen H, Karlsson T, Hjalmarson A.

Int J Cardiol. 1997 Jul 25;60(2):157-64.


Effect of endoscopic transthoracic sympathicotomy on heart rate variability in severe angina pectoris.

Tygesen H, Claes G, Drott C, Emanuelsson H, Lomsky M, Lurje L, Rådberg G, Wennerblom B, Wettervik C.

Am J Cardiol. 1997 Jun 1;79(11):1447-52.


Angina pectoris treated by thoracoscopic sympathecotomy.

Claes G, Drott C, Wettervik C, Tygesen H, Emanuelsson H, Lomsky M, Rådberg G.

Cardiovasc Surg. 1996 Dec;4(6):830-1.


Supplemental Content

Loading ...
Support Center